LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Enzyme-Loaded Magnetic Nanoparticles Suitable for Therapeutic and Industrial Applications

By LabMedica International staff writers
Posted on 25 Apr 2016
Image: An example of magnetite with sharp, lustrous, jet-black crystals (Photo courtesy of Wikimedia Commons).
Image: An example of magnetite with sharp, lustrous, jet-black crystals (Photo courtesy of Wikimedia Commons).
Members of a novel class of nano-sized transport vessels are composed of only two biocompatible components: an enzyme and magnetite nanoparticles.

Magnetically controlled enzymatic nanoparticles have received much attention for both therapeutic and industrial applications. Such materials usually comprise at least four components: the enzyme, magnetic nanoparticles, stabilizing components, and an organic or inorganic (or hybrid) matrix as a carrier. However, such combinations can affect the magnetic response and/or the enzymatic activity, and also face regulatory restrictions that prevent them from being used for intravenous administration.

To overcome these difficulties, investigators at ITMO University (St. Petersburg, Russia) and their colleagues at the Hebrew University of Jerusalem (Israel), and Cyril and Methodius University (Skopje, Macedonia) developed a new class of magnetically controlled nanoparticles made from enzymes that have been entrapped directly within magnetite particles.

These particles were made by adding enzymes directly to a magnetite hydrosol mixture. Magnetite particles surrounded the enzymes, and after drying, formed a firm porous structure from which the enzyme could not escape.

The investigators reported in the March 16, 2016, online edition of the journal Chemistry of Materials that they had used the direct entrapment approach to create a series of magnetic biocomposites with enzymes of therapeutic and industrial interest including carbonic anhydrase, ovalbumin, horseradish peroxidase, acid phosphatase, proteinase, and xylanase.

The activity of the entrapped enzymes was studied at different temperatures and concentrations, and it was found that they showed remarkable thermal stabilization induced by the magnetite matrix. For example, entrapped carbonic anhydrase catalyzed the decomposition of p-nitrophenylacetate at a temperature of 90 degrees Celsius, while the free enzyme completely lost activity and denaturized at 70 degrees Celsius.

"The nanocomposite is absolutely biocompatible and harmless for injection into the human body," said Dr. Andrey Drozdov, a research associate in the international laboratory of solution chemistry of advanced materials and technologies at ITMO University. "Separately, both magnetite and therapeutic enzymes have medical approval for intravenous injection. Therefore, to approve their joint use should not be difficult. The body already knows what to do with these substances and how to incorporate them into the process of metabolism. Using a magnetic field, the particles can be condensed on blood clots; moreover, such systems will work for quite a long time until the enzyme is completely oxidized."

Related Links:
ITMO University
Hebrew University of Jerusalem
Cyril and Methodius University
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Sample Transportation System
Tempus1800 Necto

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more